Status:

COMPLETED

trūFreeze® Spray Cryotherapy Patient Registry

Lead Sponsor:

US Endoscopy Group Inc.

Conditions:

Barrett Esophagus

Esophageal Dysplasia

Eligibility:

All Genders

18+ years

Brief Summary

To collect efficacy and outcomes data related to the use of trūFreeze® spray cryotherapy for the treatment of unwanted tissue in the pulmonary and gastrointestinal settings.

Detailed Description

This is a prospective, multi-center registry of patients who are currently undergoing spray cryotherapy using the trūFreeze® device. The registry population consists of patients who are being treated ...

Eligibility Criteria

Inclusion

  • GI conditions include:
  • Barrett's Esophagus (BE) with or without dysplasia
  • Squamous dysplasia
  • Esophageal cancer, any stage
  • Pulmonary conditions include:
  • Any endobronchial cancerous or precancerous disease located within the central airways
  • Any non-malignant endobronchial process of the central airways that results in abnormal mucosa (i.e. granulation tissue, papillomatosis, sarcoidosis, tuberculosis, etc.)
  • Tracheal or bronchial stenosis (malignant or benign)
  • Any pleural disease, malignant or benign All subjects are required to be able to provide written informed consent

Exclusion

  • Gastrointestinal Exclusion Criteria
  • Contraindication to spray cryotherapy.
  • Prior treatment with spray cryotherapy. Previous or concurrent treatment using other mucosal therapies such as endoscopic mucosal resection or radiofrequency ablation is acceptable.
  • Below 18 years of age
  • Pulmonary Exclusion Criteria
  • Contraindication to spray cryotherapy.
  • Prior treatment with spray cryotherapy. Previous or concurrent treatment using other mucosal therapies is acceptable.
  • Tracheoesophageal fistula.
  • Bronchopleural fistula.
  • Current untreated pneumothorax.
  • Clinically significant hypoxia refractory to supplemental oxygen therapy.
  • Below 18 years of age

Key Trial Info

Start Date :

April 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2022

Estimated Enrollment :

275 Patients enrolled

Trial Details

Trial ID

NCT01802203

Start Date

April 1 2013

End Date

April 1 2022

Last Update

July 25 2022

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

Scripps Green Hosptial

La Jolla, California, United States, 92037

2

University of Colorado Denver

Denver, Colorado, United States, 80045

3

Borland-Groover Clinic

Jacksonville, Florida, United States, 32256

4

Ochsner Medical Center

Kenner, Louisiana, United States, 70065